Empresa Acura Pharmaceuticals, Inc. Other OTC
Acciones
ACUR
US00509L8028
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22 % |
Ventas por región
USD en millones | 2020 | Peso | 2021 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 4 | 100,0 % | 2 | 100,0 % | -56,22 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bob Seiser
AUD | Comptroller/Controller/Auditor | 60 | 01/03/98 |
Albert Brzeczko
PRN | Corporate Officer/Principal | 67 | 01/02/09 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Peter Clemens
DFI | Director of Finance/CFO | 71 | 01/02/98 |
Bruce Wesson
BRD | Director/Board Member | 81 | 01/03/98 |
William Skelly
BRD | Director/Board Member | 73 | 01/05/96 |
Director/Board Member | 53 | 01/12/02 | |
George Ross
BRD | Director/Board Member | 82 | 01/01/08 |
Robert Jones
CEO | Chief Executive Officer | 65 | 07/04/08 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 66 001 783 | 10 081 080 ( 15,27 %) | 0 | 15,27 % |
Información de la empresa
Acura Pharmaceuticals, Inc.
616 N. North Court Suite 120
60067, Palatine
+847 705 7709
http://www.acurapharm.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |